Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine

ClinicalTrials.gov ID: NCT00000963

Public ClinicalTrials.gov record NCT00000963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 3:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Comparative Trial of Two Doses of 2',3'-Dideoxyinosine (ddI) in Children With Symptomatic HIV Infection Who Are Either Unresponsive to Zidovudine and/or Who Are Intolerant to Zidovudine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effectiveness, safety, and tolerance of two doses of didanosine (ddI) in the treatment of children with symptomatic HIV disease who have had to discontinue zidovudine (AZT) because of intolerance and/or who have experienced progressive disease while on AZT. The progression of immunodeficiency due to HIV infection can be delayed by using AZT. The benefits of AZT in adults with AIDS and severe AIDS-related complex (ARC) appear to last for approximately 12 to 18 months, at which time most patients have progressive deterioration. Recently published literature has described a reduced sensitivity of HIV isolated from patients after prolonged AZT treatment. Although the clinical significance of this is unclear, it makes the development of new antiretroviral drugs important.

Study identification

NCT ID
NCT00000963
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Sep 1995 (Actual)
Last update posted
Oct 29, 2021

Ends 1995

United States locations

U.S. sites
49
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach California 90801 —
Usc La Nichd Crs Los Angeles California 90033 —
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles California — —
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland California 94609 —
UCSD Maternal, Child, and Adolescent HIV CRS San Diego California 92093 —
UCSF Pediatric AIDS CRS San Francisco California 94143 —
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance California — —
Univ. of Connecticut Health Ctr., Dept. of Ped. Farmington Connecticut 06032 —
Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease New Haven Connecticut 06504 —
Children's National Med. Ctr., ACTU Washington D.C. District of Columbia 20010 —
Howard Univ. Washington DC NICHD CRS Washington D.C. District of Columbia 20060 —
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33161 —
Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases Atlanta Georgia 30306 —
Cook County Hosp. Chicago Illinois 60612 —
Univ. of Illinois College of Medicine at Chicago, Dept. of Peds. Chicago Illinois 60612 —
Chicago Children's CRS Chicago Illinois 60614 —
Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease Chicago Illinois 60637 —
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans Louisiana — —
Tulane/LSU Maternal/Child CRS New Orleans Louisiana — —
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology Baltimore Maryland 21201 —
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases Baltimore Maryland 21287 —
HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston Massachusetts 02115 —
BMC, Div. of Ped Infectious Diseases Boston Massachusetts 02118 —
Baystate Health, Baystate Med. Ctr. Springfield Massachusetts 01199 —
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts 01655 —
Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201 —
UMDNJ - Robert Wood Johnson New Brunswick New Jersey — —
St. Joseph's Hosp. & Med. Ctr. of New Jersey Paterson New Jersey — —
Children's Hospital at Albany Medical Center, Dept. of Peds. Albany New York 12208 —
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS Brooklyn New York 11203 —
North Shore-Long Island Jewish Health System, Dept. of Peds. Great Neck New York 11021 —
Schneider Children's Hosp., Div. of Infectious Diseases New Hyde Park New York 11040 —
NYU Med. Ctr., Dept. of Medicine New York New York 10016 —
Metropolitan Hosp. NICHD CRS New York New York 10029 —
Columbia IMPAACT CRS New York New York 10032 —
Incarnation Children's Ctr. New York New York 10032 —
Harlem Hosp. Ctr. NY NICHD CRS New York New York 10037 —
Univ. of Rochester ACTG CRS Rochester New York 14642 —
SUNY Stony Brook NICHD CRS Stony Brook New York 11794 —
SUNY Upstate Med. Univ., Dept. of Peds. Syracuse New York 13210 —
Bronx-Lebanon Hosp. IMPAACT CRS The Bronx New York 10457 —
DUMC Ped. CRS Durham North Carolina 27710 —
Case CRS Cleveland Ohio 44106 —
The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia Pennsylvania 19104 —
St. Christopher's Hosp. for Children Philadelphia Pennsylvania 19134 —
Med. Univ. of South Carolina, Div. of Ped. Infectious Diseases Charleston South Carolina 29425 —
Children's Med. Ctr. Dallas Dallas Texas 75235 —
Texas Children's Hosp. CRS Houston Texas 77030 —
UW School of Medicine - CHRMC Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2021 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00000963 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →